These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 16918876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
    Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR.
    Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB, Barclay ML.
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U, Lyrenäs E, Nilsson A, Schmiegelow K.
    Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M, Herrlinger K, Schaeffeler E, Stange EF.
    Dtsch Med Wochenschr; 2003 Feb 21; 128(8):378-85. PubMed ID: 12594624
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ, Gearry RB, Begg EJ, Zhang M, Barclay ML.
    Clin Gastroenterol Hepatol; 2008 Jun 21; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [Abstract] [Full Text] [Related]

  • 15. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
    Seidman EG.
    Rev Gastroenterol Disord; 2003 Jun 21; 3 Suppl 1():S30-8. PubMed ID: 12684587
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity].
    Corominas H, Díaz C, Vázquez G, Baiget M.
    Rev Esp Enferm Dig; 2002 Oct 21; 94(10):635-6. PubMed ID: 12647415
    [No Abstract] [Full Text] [Related]

  • 17. Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD.
    de Boer NK, van Bodegraven AA, Jharap B, de Graaf P, Mulder CJ.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec 21; 4(12):686-94. PubMed ID: 18043678
    [Abstract] [Full Text] [Related]

  • 18. Is there a role for thioguanine therapy in IBD in 2017 and beyond?
    Taylor KM, Ward MG, Blaker PA, Sparrow MP.
    Expert Rev Gastroenterol Hepatol; 2017 May 21; 11(5):473-486. PubMed ID: 28276819
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
    Gilissen LP, Bierau J, Derijks LJ, Bos LP, Hooymans PM, van Gennip A, Stockbrügger RW, Engels LG.
    Aliment Pharmacol Ther; 2005 Oct 01; 22(7):605-11. PubMed ID: 16181300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.